SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include SALUBRIS, SPLENDRIS, and SALUBRISBIO. The owner is based in Futian Dist. Shenzhen.
37F, Main Tower, Lvjing Plaza,
Che Gong Miao, No. 6009 Shennan Road,
Futian Dist. Shenzhen 518040 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. have?
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.
What trademark classes does SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. file in?
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.'s most well-known trademarks?
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.'s registered trademark portfolio includes well-known marks such as SALUBRIS, SPLENDRIS, and SALUBRISBIO. These are among 4 currently registered trademarks in the portfolio.
What is SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.'s trademark registration success rate?
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.